This is the authors' abstract. We don't add key points for this paper.
Achieving tight glycaemic control early following the diagnosis of type 2 diabetes is key to optimising clinical outcomes, yet many patients and clinicians are reluctant to initiate and intensify insulin therapy. Reasons for this arise primarily from a lack of time, clinical expertise and patient understanding. However, meaningful progress can be achieved with self-management educational programmes soon after diagnosis. Clinician education and training, along with easy-to-use and well-tolerated therapies (for example, those carrying a low risk of hypoglycaemia and/or avoiding weight gain), may also increase the likelihood of patient adherence.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Khunti et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: